Nike Inc. is asking the International Trade Commission in Washington to block imports of Adidas AG Primeknit shoes for infringing its patented invention for a knitted fabric that reduces waste while maintaining performance.
The patents are for Nike’s FlyKnit technology, which creates a sock-like fit in the upper part of the shoe by using the use of specialized yarn from recycled and reclaimed materials.
Nike said it developed the technology by spending over $100 million for a decade of research and it was the first major technological innovation in footwear uppers in decades.
The shoes that Nike hopes to ban include Adidas by Stella McCartney Ultraboost, Pharrell Williams Superstar Primeknit Shoes, and Terrex Free Hiker hiking shoes.
Nike also made similar allegations in its patent-infringement suit in federal court in Oregon.
After FlyKnit was introduced before the 2012 London Olympics, it has been adopted by hoops icon LeBron James, soccer superstar Cristiano Ronaldo, and world record marathoner Eliud Kipchoge.
Nike said that Adidas has forgone independent innovation while spending the past decade unsuccessfully challenging several of its FlyKnit technology patents while using Nike’s patented technology without permission.
According to Nike, it was forced to sue Adidas for its unauthorized use to defend its investments.
Meanwhile, Adidas said it would defend itself against the allegations..
Adidas spokeswoman Mandy Nieber claims that its Primeknit technology resulted from years of dedicated research.


Australia’s December Trade Surplus Expands but Falls Short of Expectations
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Google Halts UK YouTube TV Measurement Service After Legal Action
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings 



